NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Clinical trials for NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for chinese patients with spinal arthritis: drug shows promise in phase 3 trial
Disease control CompletedThis study tested a drug called secukinumab in 137 Chinese adults with a form of spinal arthritis that doesn't show on X-rays (non-radiographic axial spondyloarthritis). The goal was to see if the drug reduces pain, stiffness, and swelling better than a placebo after 16 weeks, an…
Matched conditions: NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:15 UTC
-
Real-world data shows how long patients stay on secukinumab for skin and joint conditions
Knowledge-focused CompletedThis study followed 127 adults with moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis for 2 years. Researchers collected real-life data on how long patients stayed on secukinumab treatment and how their q…
Matched conditions: NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC